About: Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States. The company's lead product candidate is ISLA-101, a drug which is in second clinical-stage for the prevention and treatment of dengue fever and other mosquito vector borne diseases; and Galidesivir, a spectrum antiviral candidate with the potential to address multiple high-priority RNA virus threats. Island Pharmaceuticals Limited was founded in 2017 and is based in Hawthorn East, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.29 (-10.77%)
ILA ASX Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd share price
Atividade de preço de ILA
Último preço
$ 0,290
Variação (24h)
-0,04 AUD (10,77%)
Volume
666.26K
Volume (média 4 sem.)
-
Abertura
$ 0,33
Variação do dia
$ 0,29 - $ 0,33
Fechamento anterior
$ 0,33
Último negócio
30 Oct, 5:10 am GMT+0
Atrasado
30 Oct, 5:10 am GMT+0
ILA price performance
Atrasado
30 Oct, 5:10 am GMT+0
quote.marketSignals